vs
STANDARD BIOTOOLS INC.（LAB）与PLUMAS BANCORP（PLBC）财务数据对比。点击上方公司名可切换其他公司
PLUMAS BANCORP的季度营收约是STANDARD BIOTOOLS INC.的1.5倍（$28.6M vs $19.6M），PLUMAS BANCORP同比增速更快（35.1% vs -11.5%），PLUMAS BANCORP自由现金流更多（$20.3M vs $-23.1M），过去两年PLUMAS BANCORP的营收复合增速更高（20.8% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Plumas Bancorp是一家美国银行控股公司，通过旗下子公司Plumas Bank开展业务，为加利福尼亚州北部及内华达州的个人客户、中小企业和本地社区机构提供存款、各类贷款、财富管理等综合零售及商业银行服务。
LAB vs PLBC — 直观对比
营收规模更大
PLBC
是对方的1.5倍
$19.6M
营收增速更快
PLBC
高出46.5%
-11.5%
自由现金流更多
PLBC
多$43.4M
$-23.1M
两年增速更快
PLBC
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $28.6M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 48.9% |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | 35.1% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $1.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABPLBC
| Q4 25 | — | $28.6M | ||
| Q3 25 | $19.6M | $27.4M | ||
| Q2 25 | $21.8M | $20.5M | ||
| Q1 25 | $40.8M | $21.8M | ||
| Q4 24 | — | $21.2M | ||
| Q3 24 | $22.1M | $21.1M | ||
| Q2 24 | $22.5M | $20.6M | ||
| Q1 24 | $45.5M | $19.6M |
净利润LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $5.1M | ||
| Q2 25 | $-33.5M | $6.3M | ||
| Q1 25 | $-26.0M | $7.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $7.8M | ||
| Q2 24 | $-45.7M | $6.8M | ||
| Q1 24 | $-32.2M | $6.3M |
毛利率LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABPLBC
| Q4 25 | — | 48.9% | ||
| Q3 25 | -168.5% | 25.2% | ||
| Q2 25 | -118.1% | 42.2% | ||
| Q1 25 | -80.8% | 46.1% | ||
| Q4 24 | — | 50.3% | ||
| Q3 24 | -120.9% | 50.6% | ||
| Q2 24 | -134.5% | 45.1% | ||
| Q1 24 | -132.2% | 42.8% |
净利率LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | 18.8% | ||
| Q2 25 | -153.7% | 30.8% | ||
| Q1 25 | -63.8% | 33.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | 37.1% | ||
| Q2 24 | -203.3% | 32.9% | ||
| Q1 24 | -70.6% | 31.9% |
每股收益（稀释后）LABPLBC
| Q4 25 | — | $1.56 | ||
| Q3 25 | $-0.09 | $0.73 | ||
| Q2 25 | $-0.09 | $1.05 | ||
| Q1 25 | $-0.07 | $1.20 | ||
| Q4 24 | — | $1.30 | ||
| Q3 24 | $-0.07 | $1.31 | ||
| Q2 24 | $-0.12 | $1.14 | ||
| Q1 24 | $-0.27 | $1.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $80.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $261.1M |
| 总资产 | $539.6M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABPLBC
| Q4 25 | — | $80.6M | ||
| Q3 25 | $129.4M | $87.3M | ||
| Q2 25 | $158.6M | $79.3M | ||
| Q1 25 | $150.9M | $87.3M | ||
| Q4 24 | — | $82.0M | ||
| Q3 24 | $210.6M | $118.0M | ||
| Q2 24 | $269.8M | $109.9M | ||
| Q1 24 | $287.1M | $128.2M |
总债务LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABPLBC
| Q4 25 | — | $261.1M | ||
| Q3 25 | $399.7M | $245.9M | ||
| Q2 25 | $424.5M | $193.1M | ||
| Q1 25 | $454.6M | $187.6M | ||
| Q4 24 | — | $177.9M | ||
| Q3 24 | $489.3M | $181.9M | ||
| Q2 24 | $510.3M | $165.2M | ||
| Q1 24 | $577.3M | $161.5M |
总资产LABPLBC
| Q4 25 | — | $2.2B | ||
| Q3 25 | $539.6M | $2.2B | ||
| Q2 25 | $557.0M | $1.6B | ||
| Q1 25 | $579.6M | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $681.5M | $1.7B | ||
| Q2 24 | $708.7M | $1.6B | ||
| Q1 24 | $777.7M | $1.6B |
负债/权益比LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $21.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $20.3M |
| 自由现金流率自由现金流/营收 | -118.1% | 70.9% |
| 资本支出强度资本支出/营收 | 4.5% | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $34.4M |
8季度趋势，按日历期对齐
经营现金流LABPLBC
| Q4 25 | — | $21.6M | ||
| Q3 25 | $-22.2M | $5.6M | ||
| Q2 25 | $-20.7M | $2.1M | ||
| Q1 25 | $-30.3M | $7.5M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-27.9M | $8.0M | ||
| Q2 24 | $-39.0M | $5.1M | ||
| Q1 24 | $-62.5M | $9.2M |
自由现金流LABPLBC
| Q4 25 | — | $20.3M | ||
| Q3 25 | $-23.1M | $4.8M | ||
| Q2 25 | $-22.6M | $2.0M | ||
| Q1 25 | $-35.3M | $7.3M | ||
| Q4 24 | — | $29.8M | ||
| Q3 24 | $-30.1M | $7.8M | ||
| Q2 24 | $-41.0M | $4.8M | ||
| Q1 24 | $-63.3M | $9.0M |
自由现金流率LABPLBC
| Q4 25 | — | 70.9% | ||
| Q3 25 | -118.1% | 17.5% | ||
| Q2 25 | -103.6% | 9.9% | ||
| Q1 25 | -86.6% | 33.7% | ||
| Q4 24 | — | 141.0% | ||
| Q3 24 | -136.4% | 37.1% | ||
| Q2 24 | -182.2% | 23.5% | ||
| Q1 24 | -138.9% | 45.8% |
资本支出强度LABPLBC
| Q4 25 | — | 4.6% | ||
| Q3 25 | 4.5% | 2.9% | ||
| Q2 25 | 8.7% | 0.2% | ||
| Q1 25 | 12.4% | 0.8% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 10.2% | 0.7% | ||
| Q2 24 | 8.6% | 1.1% | ||
| Q1 24 | 1.7% | 1.0% |
现金转化率LABPLBC
| Q4 25 | — | — | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.02× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 1.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PLBC
暂无分部数据
